| Pharmaceutical active ingredients: |
| Mitoxantrone |
| Available forms, composition and doses of Oncotron: |
| Injectable; Injection; Mitoxantrone 2 mg / ml |
| Oncotron medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB07 - Mitoxantrone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sun Pharmaceutical Industries |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Oncodria | Doxorubicin | Sun Pharmaceutical Industries |
| Oncomox | Tamoxifen | Sun Pharmaceutical Industries |
| Oncoplatin-AQ | Cisplatin | Sun Pharmaceutical Industries |
| Oncotaxel | Paclitaxel | Sun Pharmaceutical Industries |
| Oncotrex | Methotrexate | Sun Pharmaceutical Industries |
| Oncourcil | Fluorouracil | Sun Pharmaceutical Industries |
| Ondansetron | Ondansetron Hydrochloride | Sun Pharmaceutical Industries |
| Ondansteron | Ondansetron | Sun Pharmaceutical Industries |
| Onotrex | Methotrexate | Sun Pharmaceutical Industries |
| Ornizen | Ornidazole | Sun Pharmaceutical Industries |